SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Roos Per M.)
 

Sökning: WFRF:(Roos Per M.) > Treatment strategie...

Treatment strategies in Alzheimers disease: a review with focus on selenium supplementation

Aaseth, Jan (författare)
Innlandet Hospital Trust, Norway; Hedmark University of Appl Science, Norway
Alexander, Jan (författare)
Norwegian Institute Public Heatlh, Norway; Norwegian University of Life Science NMBU, Norway
Bjorklund, Geir (författare)
Council Nutr and Environm Med, Norway
visa fler...
Hestad, Knut (författare)
Innlandet Hospital Trust, Norway; Hedmark University of Appl Science, Norway
Dusek, Petr (författare)
Charles University of Prague, Czech Republic; Charles University of Prague, Czech Republic; Gen University Hospital Prague, Czech Republic
Roos, Per M. (författare)
Karolinska Institutet,Karolinska Institute, Sweden; St Goran Hospital, Sweden
Alehagen, Urban (författare)
Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US
visa färre...
 (creator_code:org_t)
2016-08-16
2016
Engelska.
Ingår i: Biometals. - : SPRINGER. - 0966-0844 .- 1572-8773. ; 29:5, s. 827-839
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Alzheimers disease (AD) is a neurodegenerative disorder presenting one of the biggest healthcare challenges in developed countries. No effective treatment exists. In recent years the main focus of AD research has been on the amyloid hypothesis, which postulates that extracellular precipitates of beta amyloid (A beta) derived from amyloid precursor protein (APP) are responsible for the cognitive impairment seen in AD. Treatment strategies have been to reduce A beta production through inhibition of enzymes responsible for its formation, or to promote resolution of existing cerebral A beta plaques. However, these approaches have failed to demonstrate significant cognitive improvements. Intracellular rather than extracellular events may be fundamental in AD pathogenesis. Selenate is a potent inhibitor of tau hyperphosphorylation, a critical step in the formation of neurofibrillary tangles. Some selenium (Se) compounds e.g. selenoprotein P also appear to protect APP against excessive copper and iron deposition. Selenoproteins show anti-inflammatory properties, and protect microtubules in the neuronal cytoskeleton. Optimal function of these selenoenzymes requires higher Se intake than what is common in Europe and also higher intake than traditionally recommended. Supplementary treatment with N-acetylcysteine increases levels of the antioxidative cofactor glutathione and can mediate adjuvant protection. The present review discusses the role of Se in AD treatment and suggests strategies for AD prevention by optimizing selenium intake, in accordance with the metal dysregulation hypothesis. This includes in particular secondary prevention by selenium supplementation to elderly with mild cognitive impairment.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Nyckelord

Alzheimers disease; Copper; Iron; Neuroinflammation; Transmitters; Selenium

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

  • Biometals (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy